Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

586
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
586

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mucin degradation by Akkermansia muciniphila promotes Alistipes-dependent tryptophan metabolism and Th17-driven autoimmunity.

Mucosal immunology·2026
Same author

Designing studies for post-treatment Lyme disease and other infection-associated chronic illnesses.

Brain : a journal of neurology·2026
Same author

Special Edition: Therapeutic advances in multiple sclerosis.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2025
Same author

Impact of sex on multiple sclerosis therapy.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2025
Same author

How Do I Approach the Evaluation and Treatment of Early Lyme Disease?

NEJM evidence·2024
Same author

SARS-CoV-2 infection increases long-term multiple sclerosis disease activity and all-cause mortality in an underserved inner-city population.

Multiple sclerosis and related disorders·2024
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.6K

Multiple sclerosis in pregnancy.

Patricia K Coyle

    Continuum (Minneapolis, Minn.)
    |February 5, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Pregnancy significantly impacts multiple sclerosis (MS) disease activity, with reduced activity during gestation and increased activity postpartum. Long-term progression is not worsened by pregnancy in relapsing MS.

    More Related Videos

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
    08:51

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

    Published on: February 19, 2021

    9.7K
    Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
    05:55

    Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

    Published on: December 1, 2023

    1.4K

    Related Experiment Videos

    Last Updated: May 3, 2026

    Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
    05:44

    Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

    Published on: October 13, 2023

    2.6K
    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
    08:51

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

    Published on: February 19, 2021

    9.7K
    Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
    05:55

    Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

    Published on: December 1, 2023

    1.4K

    Area of Science:

    • Neurology
    • Reproductive Medicine
    • Immunology

    Background:

    • Multiple sclerosis (MS) commonly affects women of childbearing age, necessitating understanding of pregnancy interactions.
    • Reproductive counseling is crucial for managing MS during pregnancy.
    • Current research focuses on the dynamic relationship between MS and pregnancy.

    Observation:

    • MS disease activity typically decreases in the third trimester of pregnancy.
    • A marked increase in MS relapses occurs in the postpartum period (first 3 months).
    • Pre-pregnancy disability and relapses during pregnancy are linked to higher postpartum attack risks.

    Findings:

    • Pregnancy does not appear to worsen long-term disease progression in relapsing MS, and may even lessen it.
    • Evidence regarding pregnancy's effect on progressive MS long-term outcomes is less clear.
    • No teratogenic effects have been documented for MS disease-modifying therapies in humans to date.
    • Teriflunomide is the only MS therapy requiring male contraception due to its presence in semen.

    Implications:

    • Understanding the mechanisms behind pregnancy's effect on MS could yield new therapeutic strategies.
    • This knowledge is vital for informed reproductive counseling of MS patients.
    • Further research is needed to clarify pregnancy's impact on progressive MS.